Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain.

Vincenzi, Martina; Milella, Michele Stanislaw; D'Ottavio, Ginevra; Caprioli, Daniele; Reverte, Ingrid; Maftei, Daniela

Vincenzi, Martina; Milella, Michele Stanislaw; D'Ottavio, Ginevra; Caprioli, Daniele; Reverte, Ingrid; Maftei, Daniela.

Afiliação

Vincenzi M; Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, 00185 Rome, Italy.
Milella MS; Toxicology and Poison Control Center Unit, Department of Emergency, Anesthesia and Critical Care, Policlinico Umberto I Hospital-Sapienza University of Rome, 00161 Rome, Italy.
D'Ottavio G; Santa Lucia Foundation (IRCCS Fondazione Santa Lucia), 00143 Rome, Italy.
Caprioli D; Laboratory Affiliated to Institute Pasteur Italia-Fondazione Cenci Bolognetti, Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, 00185 Rome, Italy.
Reverte I; Santa Lucia Foundation (IRCCS Fondazione Santa Lucia), 00143 Rome, Italy.
Maftei D; Laboratory Affiliated to Institute Pasteur Italia-Fondazione Cenci Bolognetti, Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, 00185 Rome, Italy.

Life (Basel) ; 12(3)2022 Mar 09.

Article em En | MEDLINE | ID: mdl-35330149

Palavras-chave

GPCRs; chemokine receptor antagonist; chemokine receptors; chemokines; neuropathic pain; strong opioids

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Life (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google